Rubén Armañanzas is a scientist with 20 years of experience in artificial intelligence, machine learning, bio & neuro informatics, and biomedical applications. He obtained his doctoral degree in 2009 (extraordinary doctorate award 2008/2009) at the University of the Basque Country (San Sebastián, Spain). He moved to Madrid to work at the Technical University of Madrid within the Cajal Blue Brain Project until fall 2013. He held a faculty position in the Bioengineering Department and an affiliate faculty of the Interdisciplinary Program in Neuroscience at George Mason University (Fairfax, US) until late 2018. Rubén moved to industry in early 2019 as the Manager of the Algorithm Development team at BrainScope Company Inc. (Bethesda, MD) where he managed project planning and execution of the Research & Development department, implemented de-novo algorithms, acted as cross-unit liaison, and coordinated & designed clinical trials. In late 2020, he joined the Basque Center for Applied Mathematics (Bilbao, Spain) as Senior Classification Engineer designing and implementing an early prognostic algorithm to triage COVID-19 patients at the point of care. He is currently a Principal Investigator on Digital Medicine at the Institute of Data Science and Artificial Intelligence (DATAI) of the Universidad de Navarra (Pamplona, Spain).